← Evidence map

ReviewIslets

Antigen-based vs. systemic immunomodulation in type 1 diabetes: the pros and cons.

Sofie Robert et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

7 papers cite it

2015
2016
2017
2018
2019
2020
2021
2022
2023
pooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 23648893